Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) EBIT Margin (2017 - 2025)

Historic EBIT Margin for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to 2.74%.

  • Selectis Health's EBIT Margin rose 89600.0% to 2.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.0%, marking a year-over-year increase of 116900.0%. This contributed to the annual value of 6.91% for FY2024, which is 174500.0% up from last year.
  • As of Q3 2025, Selectis Health's EBIT Margin stood at 2.74%, which was up 89600.0% from 4.31% recorded in Q2 2025.
  • Selectis Health's EBIT Margin's 5-year high stood at 11.53% during Q2 2022, with a 5-year trough of 32.53% in Q4 2023.
  • For the 5-year period, Selectis Health's EBIT Margin averaged around 7.48%, with its median value being 5.3% (2021).
  • Per our database at Business Quant, Selectis Health's EBIT Margin plummeted by -321600bps in 2021 and then soared by 315900bps in 2024.
  • Quarter analysis of 5 years shows Selectis Health's EBIT Margin stood at 11.4% in 2021, then dropped by -16bps to 13.27% in 2022, then tumbled by -145bps to 32.53% in 2023, then surged by 97bps to 0.94% in 2024, then tumbled by -193bps to 2.74% in 2025.
  • Its EBIT Margin was 2.74% in Q3 2025, compared to 4.31% in Q2 2025 and 4.02% in Q1 2025.